These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6735995)

  • 1. The importance of dose in isocarboxazid therapy.
    Davidson J; Turnbull C
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):49-52. PubMed ID: 6735995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.
    Giller E; Bialos D; Harkness L; Riddle M
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):44-8. PubMed ID: 6376484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of isocarboxazid on platelet MAO activity.
    Davidson J; White H
    Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004
    [No Abstract]   [Full Text] [Related]  

  • 4. Side effects of isocarboxazid.
    Zisook S
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):53-8. PubMed ID: 6376485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of depressed inpatients to isocarboxazid.
    Davidson J; Lipper S; Pelton S; Miller RD; Hammett EB; Mahorney S; Varia IM
    J Clin Psychopharmacol; 1988 Apr; 8(2):100-7. PubMed ID: 3372704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAO inhibitor therapy in trichotillomania associated with depression: case report.
    Krishnan RR; Davidson J; Miller R
    J Clin Psychiatry; 1984 Jun; 45(6):267-8. PubMed ID: 6725219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High initial nortriptyline doses in the treatment of depression.
    Warner MD; Griffin M; Peabody CA
    J Clin Psychiatry; 1993 Feb; 54(2):67-9. PubMed ID: 8444823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report.
    Davidson J; Sullivan JL
    J Clin Psychopharmacol; 1983 Feb; 3(1):42-3. PubMed ID: 6833523
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
    Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
    Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of two doses of isocarboxazid in depression.
    Davidson J; Miller R; Turnbull CD; Belyea M; Strickland R
    J Affect Disord; 1984 Apr; 6(2):201-7. PubMed ID: 6233352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for fluoxetine-MAOI combination therapy.
    Peterson GN
    J Clin Psychiatry; 1991 Feb; 52(2):87-8. PubMed ID: 1993642
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
    Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of appetite and weight associated with the monoamine oxidase inhibitor isocarboxazid.
    Davidson J; Turnbull C
    J Clin Psychopharmacol; 1982 Aug; 2(4):263-6. PubMed ID: 7119133
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase inhibitor-responsive depression.
    Giller E; Bialos D; Riddle M; Sholomskas A; Harkness L
    Psychiatry Res; 1982 Feb; 6(1):41-8. PubMed ID: 7036196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels.
    Ertugrul A; Ucar G; Basar K; Demir B; Yabanoglu S; Ulug B
    Psychiatry Res; 2007 Jan; 149(1-3):49-57. PubMed ID: 17157920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of outpatients with desipramine.
    Rosenbaum JF
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):17-22. PubMed ID: 6384206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.